Filter Results:
(2,749)
Show Results For
- All HBS Web
(5,654)
- People (16)
- News (2,051)
- Research (2,749)
- Events (8)
- Multimedia (223)
- Faculty Publications (1,961)
Show Results For
- All HBS Web
(5,654)
- People (16)
- News (2,051)
- Research (2,749)
- Events (8)
- Multimedia (223)
- Faculty Publications (1,961)
Sort by
- 2024
- Article
Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway
By: Mateo Aboy, Cristina Crespo and Ariel Stern
Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technology Adoption; Technological Innovation; Safety; Medical Devices and Supplies Industry; United States
Aboy, Mateo, Cristina Crespo, and Ariel Stern. "Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway." Art. 29. npj Digital Medicine 7 (2024).
- February 2019 (Revised August 2019)
- Case
Maccabitech: The Promise of Israel's Healthcare Data
By: Scott Duke Kominers and Carin-Isabel Knoop
Dr. Varda Shalev bridges technology and medicine through Maccabitech, a "research and innovation wing" of Israel's Maccabi Healthcare Services (MHS) that partners with research institutions, pharmaceutical companies, and startups. Shalev hopes to scale Maccabitech's... View Details
Keywords: Big Data; Healthcare; Analytics and Data Science; Digital Platforms; Health Care and Treatment; Innovation and Invention; Research; Entrepreneurship; Risk Management; Israel
Kominers, Scott Duke, and Carin-Isabel Knoop. "Maccabitech: The Promise of Israel's Healthcare Data." Harvard Business School Case 819-032, February 2019. (Revised August 2019.)
- February 2011 (Revised June 2011)
- Case
Hardina Smythe and the Healthcare Investment Conundrum
By: Matthew Rhodes-Kropf, Ann Leamon and Lisa Strope
Hardina Smythe, a recent MBA graduate, has just joined a top-tier venture capital firm in the difficult environment of late 2010. Her first assignment is to evaluate three different deals and make recommendations to the partners. Each potential investment has strengths... View Details
Keywords: Venture Capital; Asset Management; Private Equity; Entrepreneurship; Investment; Health Care and Treatment; Innovation and Invention; Financial Services Industry
Rhodes-Kropf, Matthew, Ann Leamon, and Lisa Strope. "Hardina Smythe and the Healthcare Investment Conundrum." Harvard Business School Case 811-073, February 2011. (Revised June 2011.)
- 17 Mar 2011
- Research & Ideas
Harvard Business School Faculty Comment on Crisis in Japan
ahead for Japan's business leaders and for global companies operating in Japan. Rohit Deshpande, Sebastian S. Kresge Professor of Marketing The culture of Japan tends to be outer directed. Thus, taking care of other people becomes much... View Details
Keywords: Re: Multiple Faculty
- October 2003 (Revised January 2005)
- Case
Shared Decision Making
By: Richard M.J. Bohmer, Karen Sepucha and Laura Feldman
The Foundation for Informed Medical Decision-Making has created an interactive videodisc system that provides patients with customized support regarding medical treatment or screening decisions when they face a choice between two equally effective courses of action.... View Details
Keywords: Decision Choices and Conditions; Borrowing and Debt; Health Care and Treatment; Innovation Strategy; Technological Innovation; Product Marketing; Distribution Channels; Production; Partners and Partnerships; Research and Development; Information Technology
Bohmer, Richard M.J., Karen Sepucha, and Laura Feldman. "Shared Decision Making." Harvard Business School Case 604-001, October 2003. (Revised January 2005.)
- 19 Jun 2007
- First Look
First Look: June 19, 2007
develop this perceptions framework is of a single stage stochastic inventory system with periodic review, constant leadtimes, infinite supply, full backlogging, linear holding and penalty costs and no ordering costs. Forecasting ARIMA... View Details
Keywords: Martha Lagace
- 18 Dec 2012
- First Look
First Look: December 18
their propensity to make things themselves (Experiments 3A and 3B). Paper: http://www.people.hbs.edu/mnorton/mochon norton ariely 2012.pdf Measuring Teamwork in Health Care Settings: A Review of Survey... View Details
Keywords: Carmen Nobel
- 24 Jul 2013
- Op-Ed
Detroit Files for Bankruptcy: HBS Faculty Weigh In
city employees are legally protected by many state constitutions. The key constraint in changing health care obligations, however, is usually political, especially pressure from public employee unions. If... View Details
- 19 Dec 2014
- Research & Ideas
China’s Complicated Relationship With Mother Nature
Despite its name, the Great Wall of China began as a series of smaller, isolated defensive fortifications. Those structures grew and were later unified into the imposing structure that exists today. The Great Wall is a great metaphor for the Chinese economy. By... View Details
- 02 Jun 2011
- Research & Ideas
Signing at the Top: The Key to Preventing Tax Fraud?
The instructions went on to say that the participants would receive a tax credit for the cost of their commute to the lab. After the problem-solving exercise, the participants went into another room and filled out a "research study tax... View Details
- 05 Mar 2013
- First Look
First Look: March 5
abstract available. Purchase this case:http://hbr.org/search/213051-PDF-ENG Kirkpatrick Corporation Hawkins, David F. Harvard Business School Case 113-070 No abstract available. Purchase this case:http://hbr.org/search/113070-PDF-ENG Social Media in View Details
Keywords: Sean Silverthorne
- 26 Apr 2016
- First Look
April 26
opened to cover the secondary health-care needs of the health department's inhabitants. In 2003, the model was extended to also cover primary care. The health department received a capitation fee for each... View Details
Keywords: Sean Silverthorne
- 05 Mar 2019
- First Look
New Research and Ideas, March 5, 2019
forthcoming Journal of Financial and Quantitative Analysis Leverage and the Beta Anomaly By: Baker, Malcolm, Mathias F. Hoeyer, and Jeffrey Wurgler Abstract— The well-known weak empirical relationship between beta risk and the cost of... View Details
Keywords: Dina Gerdeman
- 09 Aug 2004
- Research & Ideas
A Diagnostic for Disruptive Innovation
established market. Mapping a product's or service's delivery chain can identify opportunities where removing a link from the delivery chain will allow people to do for themselves what they previously had to rely on others to do for them. The View Details
- 03 Nov 2009
- First Look
First Look: Nov. 3
costs decrease and as the benefits from outsourcing the use of intellectual property increases. We also examine how different licensing arrangements affect the relation between the variance of the returns to the intellectual property and... View Details
Keywords: Martha Lagace
- 30 Jan 2017
- Research & Ideas
Vanguard, Trian And The Problem With 'Passive' Index Funds
On August 31, 2016, many investors celebrated the 40th birthday of one of the world’s most successful financial instruments: the mutual index fund, created by Vanguard founder John C. Bogle. Index funds, which automatically track an index of stocks such as the S&P... View Details
- 2014
- Working Paper
Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms
By: Prithwiraj Choudhury and Tarun Khanna
Since the 1990s, several Western firms have filed patents based on medicinal herbs from emerging markets, evoking protests from local stakeholders against 'bio-piracy'. We explore conditions under which firms and local stakeholders share rents from such patents. Our... View Details
Keywords: Rents From New Technology; Local Stakeholders; Herbal Patents; QCA; Fuzzy Set Analysis; Qualitative Case Studies; Plant-Based Agribusiness; Patents; Emerging Markets; Health Care and Treatment; Business and Stakeholder Relations; Cross-Cultural and Cross-Border Issues; Agriculture and Agribusiness Industry; Pharmaceutical Industry
Choudhury, Prithwiraj, and Tarun Khanna. "Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms." Harvard Business School Working Paper, No. 14-081, February 2014.
- August 2009 (Revised April 2012)
- Case
Genzyme's CSR Dilemma: How to Play its HAND
By: Christopher A. Bartlett, Tarun Khanna and Prithwiraj Choudhury
Genzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases (e.g., malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should... View Details
Keywords: Global Strategy; Health Care and Treatment; Intellectual Property; Corporate Social Responsibility and Impact; Partners and Partnerships; Research and Development; Biotechnology Industry
Bartlett, Christopher A., Tarun Khanna, and Prithwiraj Choudhury. "Genzyme's CSR Dilemma: How to Play its HAND." Harvard Business School Case 910-407, August 2009. (Revised April 2012.)
- 07 Apr 2011
- What Do You Think?
When Should the Public Sector Take Over in a Meltdown?
them lack of public credit for prevention (as opposed to recovery), political opposition to preemptive actions, and the sheer cost of insuring against meltdowns (Phil Clark). David Physick responds with questions: "Is the question... View Details
- 15 May 2020
- Research & Ideas
Find Your Pragmatic Path through Radical Uncertainty
the future. Process planning and scenario planning make more sense than fixed projections because they focus on answerable questions. What is required to remain solvent per month? What startup costs will be required to return to “normal?”... View Details